JENSCARE-B (09877): Ken-Valve and LuX-Valve Plus Secure Registration Approval in New Zealand

Stock News

Feb 26

Jenscare Scientific Company Limited (09877) has announced that its transcatheter aortic valve replacement system, Ken-Valve, and its transvascular tricuspid valve replacement system, LuX-Valve Plus, have recently obtained registration approval from New Zealand's Medicines and Medical Devices Safety Authority. The company is actively advancing the commercialization of both products in New Zealand. Benefiting from their design advantages, completed pivotal clinical trials, and ongoing therapy promotion efforts, Ken-Valve and LuX-Valve Plus have gained broad market recognition. With the registration approval from New Zealand's regulatory authority for these two key products, the company will accelerate the global commercialization of its product portfolio to further achieve its long-term strategic objectives.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1174718009"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1174718009\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1174718009?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 08:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174718009","market":"us","top_or_hot":-1,"title":"JENSCARE-B (09877): Ken-Valve and LuX-Valve Plus Secure Registration Approval in New Zealand","media":"Stock News","content":"<p>Jenscare Scientific Company Limited (09877) has announced that its transcatheter aortic valve replacement system, Ken-Valve, and its transvascular tricuspid valve replacement system, LuX-Valve Plus, have recently obtained registration approval from New Zealand's Medicines and Medical Devices Safety Authority. The company is actively advancing the commercialization of both products in New Zealand. Benefiting from their design advantages, completed pivotal clinical trials, and ongoing therapy promotion efforts, Ken-Valve and LuX-Valve Plus have gained broad market recognition. With the registration approval from New Zealand's regulatory authority for these two key products, the company will accelerate the global commercialization of its product portfolio to further achieve its long-term strategic objectives.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JENSCARE-B (09877): Ken-Valve and LuX-Valve Plus Secure Registration Approval in New Zealand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJENSCARE-B (09877): Ken-Valve and LuX-Valve Plus Secure Registration Approval in New Zealand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-02-26 08:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jenscare Scientific Company Limited (09877) has announced that its transcatheter aortic valve replacement system, Ken-Valve, and its transvascular tricuspid valve replacement system, LuX-Valve Plus, have recently obtained registration approval from New Zealand's Medicines and Medical Devices Safety Authority. The company is actively advancing the commercialization of both products in New Zealand. Benefiting from their design advantages, completed pivotal clinical trials, and ongoing therapy promotion efforts, Ken-Valve and LuX-Valve Plus have gained broad market recognition. With the registration approval from New Zealand's regulatory authority for these two key products, the company will accelerate the global commercialization of its product portfolio to further achieve its long-term strategic objectives.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09877","symbol_name":"健世科技-B","start_time":0,"source_url":"","article_id":"1174718009","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174718009","pubTimestamp":1772064944,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Jenscare Scientific Company Limited (09877) has announced that its transcatheter aortic valve replacement system, Ken-Valve, and its transvascular tricuspid valve replacement system, LuX-Valve Plus,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09877":"健世科技-B","BK1100":"医疗保健设备"},"translate_title":"JENSCARE-B(09877)：Ken-Valve和LuX-Valve Plus在新西兰获得注册批准","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09877":1},"content_text":"Jenscare Scientific Company Limited (09877) has announced that its transcatheter aortic valve replacement system, Ken-Valve, and its transvascular tricuspid valve replacement system, LuX-Valve Plus, have recently obtained registration approval from New Zealand's Medicines and Medical Devices Safety Authority. The company is actively advancing the commercialization of both products in New Zealand. Benefiting from their design advantages, completed pivotal clinical trials, and ongoing therapy promotion efforts, Ken-Valve and LuX-Valve Plus have gained broad market recognition. With the registration approval from New Zealand's regulatory authority for these two key products, the company will accelerate the global commercialization of its product portfolio to further achieve its long-term strategic objectives.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}